Lobbying

Envigo RMS's latest lobbying report covers Q3 2024, at $6,500. Its first report covers Q4 2021; the issues it reports most are Medical/Disease Research/Clinical Labs and Government Issues.

Envigo RMS

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2021
The first quarter a report named it

Lobbying by quarter

Envigo RMS lobbying by quarter
Envigo RMS lobbying by quarter
QuarterAmountReports
Q4 2021$50K1
Q1 2022$00
Q2 2022$00
Q3 2022$00
Q4 2022$15K1
Q1 2023$15K1
Q2 2023$15K1
Q3 2023$11.5K1
Q4 2023$11.5K1
Q1 2024$11.5K1
Q2 2024$26K1
Q3 2024$6,5001
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medical research and clinical labs$104.5K · 7 reports
  • Government issues$25K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE7 reports
  • HOUSE OF REPRESENTATIVES4 reports
  • Commerce, Dept of (DOC)1 reports
  • Food & Drug Administration (FDA)1 reports
  • Health & Human Services, Dept of (HHS)1 reports
  • Natl Economic Council (NEC)1 reports
  • Office of Science & Technology Policy (OSTP)1 reports
  • Office of the Vice President of the United States1 reports

Firms it paid

Firm
Ben Barnes Group$112K8 quarters
Barnes & Thornburg$50K1 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
24/10/10for Q3 2024Ben Barnes Group$6,500
24/07/12for Q2 2024Ben Barnes Group$26K
24/07/12for Q2 2024Ben Barnes GroupUnder $5,000
24/04/07for Q1 2024Ben Barnes Group$11.5K
24/01/07for Q4 2023Ben Barnes Group$11.5K
24/01/02for Q4 2021Barnes & Thornburg$50K
23/10/12for Q3 2023Ben Barnes Group$11.5K
23/07/11for Q2 2023Ben Barnes Group$15K
23/04/11for Q1 2023Ben Barnes Group$15K
23/01/07for Q4 2022Ben Barnes Group$15K